Postdoctoral and Research Associate positions in cancer immunotherapy

The Eschweiler lab in the department of Experimental Therapeutics at the University of Texas MD Anderson Cancer Center is seeking highly motivated postdoctoral researchers and research technicians (RA I – Senior Research Associates) for positions in cancer immunology & immunotherapy. The lab employs genomic tools, novel mouse tumor models and computational approaches to understand the immunological basis of cancer.

Qualified Candidates should have:

Postdoctoral Researcher

• PhD in immunology, molecular biology, biochemistry, cancer biology or a related field

• Evidence of strong scientific productivity, demonstrated by high-quality research published in peerreviewed journals

• Skills for internal and collaborative projects

• A strong sense of curiosity and willingness to explore different avenues

Research Technician

• Bachelor’s degree (BS/BA) in biology, biochemistry or related field

• 1-5 years of lab experience in an academic setting (preferable but not necessary)

• Ability to illustrate the conceptual significance of previous work/training experiences.

Strong applicants will have knowledge or skills in one or more of the following areas:

• Tumor immunology & cancer immunotherapy

• In vivo mouse models

• Mouse handling & colony maintenance

• Cell culture of cancer cell lines & primary cells

• Multi-color flow cytometry (FACS) & cell sorting

• Single-cell RNA-seq & ATAC-seq

• Data analysis & interpretation

To apply please review the following papers and provide a CV and Cover Letter to: ETAppointment@mdanderson.org

a. Eschweiler S, et al. Intermittent PI3Kd inhibition sustains anti-tumor immunity and curbs irAEs. Nature, 2022. PMID: 35508656.

b. Eschweiler S, et al. Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment e?icacy. Nature Immunology, 2021. PMCID: PMC8434898.

c. Eschweiler S, et al. JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells. Cell Reports, 2023 PMID: 36701231

d. MeckiC BJ, et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell, 2020. PMID: 33096020.

e. Clarke J, et al. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer. Journal of Experimental Medicine, 2019. PMCID: PMC6719422